Compare ASMB & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | ENVX |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 612.3M |
| IPO Year | 2010 | 2020 |
| Metric | ASMB | ENVX |
|---|---|---|
| Price | $19.95 | $1.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $51.20 | $9.75 |
| AVG Volume (30 Days) | 201.9K | ★ 9.5M |
| Earning Date | 11-24-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | 40.94 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $31,821,000.00 |
| Revenue This Year | N/A | $23.31 |
| Revenue Next Year | N/A | $93.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 37.91 |
| 52 Week Low | $19.20 | $2.19 |
| 52 Week High | $39.71 | $9.19 |
| Indicator | ASMB | ENVX |
|---|---|---|
| Relative Strength Index (RSI) | 42.68 | 33.68 |
| Support Level | $19.25 | N/A |
| Resistance Level | $21.65 | $3.01 |
| Average True Range (ATR) | 1.16 | 0.35 |
| MACD | 0.37 | -0.08 |
| Stochastic Oscillator | 26.65 | 4.76 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.